Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Belated Introduction to Dr. Charu Aggarwal
Author
Howard (Jack) West, MD

Many of you already participating on the lung cancer section of the GRACE site have seen the first few responses by Dr. Aggarwal, though they have preceded my proper introduction of her.  Apologies -- we had talked a few months ago about having her start sometime around now, though I hadn't anticipated her laudable enthusiasm and courage to jump right in.  So let me now provide a little background.  

Dr. Charu Aggarwal is an Assistant Professor in the Hematology/Oncology Division at the University of Pennsylvania, where she has a particular focus on lung cancer.  She started her medical training at the Lady Hardinge Medical College in New Delhi, then came to the US and did a Master’s in Public Health at the University of Alabama, Birmingham.  She then did her internship and residency training in internal medicine at the State University of New York, Buffalo before moving to Philadelphia to do her medical oncology fellowship training at the Fox Chase Cancer Center.   Last year she moved to the University of Pennsylvania to join their faculty.  

 

Our friend Dr. Weiss here has known Dr. Aggarwal from his time in Philadelphia, as he had trained at the University of Pennsylvania and knew Dr. Aggarwal from the cancer scene in Philadelphia (I guess if you consider there to be such a thing).  He had recommended here, and I've had the chance to spend some time talking with and trying to recruit her to work with us.  Her background includes an impressive collection of awards for academic achievements, her research efforts, and bedside manner -- I think this is a great combination that I hope will lead to her becoming a recurring, always welcomed addition to the GRACE faculty.

 

Next Previous link

Previous PostNext Post

Related Content

Article
The journey to conquer lung cancer is paved with scientific discovery, and the identification of the EGFR and ALK genes as crucial players marks a significant milestone. Unraveling how mutations in these seemingly small segments of our DNA can unleash the destructive force of cancer has opened up exciting new therapeutic avenues. This exploration delves into the cutting-edge world of EGFR and ALK-targeted therapies, highlighting the progress made and the ongoing quest for even more effective and personalized strategies to combat this formidable disease.
Image
Rare cancers
Video
In these videos,  Dr. Jared Weiss gives a brief overview of NUT Carcinoma, discusses treatment options and possible future treatment.  To watch the complete playlist, click here.  
Article
Don't let the word "small" deceive you. Small cell lung cancer (SCLC) casts a long shadow, impacting lives with its aggressive nature and the complexities of its treatment. But while the challenges are real, so is the progress. Breakthroughs in small cell lung cancer treatment offer hope. Immunotherapy plus chemo-radiation improves survival by 22 months. Screening catches it early.

Forum Discussions

Can SCLC also be treated with targeted therapy?

Hi amitchouhan,

Welcome to Grace. At this time, there aren't any targeted therapies to treat SCLC, but there are new treatments. Check out our latest OncTalk webinar from December. The last...

I was searching for this, Thank you so much for the info.

Recent Comments

JOIN THE CONVERSATION
Yes, it's crucial to discuss…
By JanineT GRACE … on
Definitely a good idea to…
By OakleeFarnick on
Thank you for sharing
By LeviDrake on
Hi bluesun,I don't know of…
By JanineT GRACE … on